$BEAM
Beam Therapeutics Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022022322 Filed on November 07, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $20.04M $15.80M $763.0K
YoY Change -60.76% 1970.64% 12616.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $22.68M $21.82M $15.77M
YoY Change 27.62% 38.3% 110.32%
% of Gross Profit
Research & Development $86.34M $85.29M $54.62M
YoY Change -10.79% 56.14% 83.15%
% of Gross Profit
Depreciation & Amortization $3.944M $3.473M $1.675M
YoY Change 49.73% 107.34% 37.52%
% of Gross Profit
Operating Expenses $109.0M $107.1M $70.40M
YoY Change -4.83% 52.14% 88.6%
Operating Profit -$91.30M -$69.63M
YoY Change 31.12% 86.58%
Interest Expense $32.19M $10.51M $30.92M
YoY Change -321.9% -66.0% 977.25%
% of Operating Profit
Other Income/Expense, Net $19.45M $9.638M $41.52M
YoY Change 46.41% -76.78% 1347.05%
Pretax Income -$37.35M -$81.67M -$28.12M
YoY Change -42.28% 190.44% -18.38%
Income Tax $1.000M $2.410M $0.00
% Of Pretax Income
Net Earnings -$38.35M -$109.6M -$28.12M
YoY Change -40.73% 289.7% -18.38%
Net Earnings / Revenue -191.39% -693.56% -3685.19%
Basic Earnings Per Share -$1.56 -$0.42
Diluted Earnings Per Share -$0.54 -$1.56 -$0.42
COMMON SHARES
Basic Shares Outstanding 70.47M 70.35M 66.38M
Diluted Shares Outstanding 70.34M 66.38M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.078B $1.095B $933.4M
YoY Change 11.65% 17.26% 361.62%
Cash & Equivalents $232.8M $156.5M $612.0M
Short-Term Investments $845.4M $938.0M $321.4M
Other Short-Term Assets $14.76M $14.36M $8.019M
YoY Change 100.57% 79.05% 23.37%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.093B $1.109B $941.4M
YoY Change -14.15% 17.79% 351.09%
LONG-TERM ASSETS
Property, Plant & Equipment $115.6M $111.2M $71.53M
YoY Change 37.22% 55.42% 39.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $24.54M
YoY Change
Other Assets $1.931M $1.874M $1.051M
YoY Change 12.01% 78.31% -94.29%
Total Long-Term Assets $248.8M $241.3M $215.1M
YoY Change 23.52% 12.18% 209.1%
TOTAL ASSETS
Total Short-Term Assets $1.093B $1.109B $941.4M
Total Long-Term Assets $248.8M $241.3M $215.1M
Total Assets $1.342B $1.350B $1.157B
YoY Change -9.0% 16.75% 315.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.029M $7.024M $7.282M
YoY Change 20.81% -3.54% 10.33%
Accrued Expenses $58.44M $48.42M $29.45M
YoY Change -22.29% 64.43% 30.31%
Deferred Revenue $136.0M $159.9M $12.82M
YoY Change 57.61% 1147.09%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.853M $2.210M $2.238M
YoY Change -18.98% -1.25% 31.65%
Total Short-Term Liabilities $223.6M $238.9M $101.4M
YoY Change 4.76% 135.58% 113.45%
LONG-TERM LIABILITIES
Long-Term Debt $1.154M $1.388M $3.598M
YoY Change -61.62% -61.42% -18.23%
Other Long-Term Liabilities $224.0K $253.0K $852.0K
YoY Change -91.98% -70.31% -96.76%
Total Long-Term Liabilities $224.0K $253.0K $852.0K
YoY Change -91.98% -70.31% -97.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $223.6M $238.9M $101.4M
Total Long-Term Liabilities $224.0K $253.0K $852.0K
Total Liabilities $608.2M $635.8M $302.7M
YoY Change -6.09% 110.01% 287.14%
SHAREHOLDERS EQUITY
Retained Earnings -$1.100B -$1.000B -$703.6M
YoY Change 43.18% 42.13%
Common Stock $712.0K $705.0K $677.0K
YoY Change 4.09% 4.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $733.5M $714.5M $853.8M
YoY Change
Total Liabilities & Shareholders Equity $1.342B $1.350B $1.157B
YoY Change -9.0% 16.75% 315.58%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$38.35M -$109.6M -$28.12M
YoY Change -40.73% 289.7% -18.38%
Depreciation, Depletion And Amortization $3.944M $3.473M $1.675M
YoY Change 49.73% 107.34% 37.52%
Cash From Operating Activities -$69.19M -$74.50M $3.007M
YoY Change -3880.93% -2577.42% -114.18%
INVESTING ACTIVITIES
Capital Expenditures $8.261M -$11.79M -$5.780M
YoY Change -161.79% 103.93% 104.96%
Acquisitions
YoY Change
Other Investing Activities $121.7M -$24.39M $81.90M
YoY Change -289.78% -129.78% 115.23%
Cash From Investing Activities $113.4M -$36.17M $76.11M
YoY Change -246.38% -147.53% 116.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 32.01M 1.562M 320.9M
YoY Change 48.6% -99.51% 356440.0%
NET CHANGE
Cash From Operating Activities -69.19M -74.50M 3.007M
Cash From Investing Activities 113.4M -36.17M 76.11M
Cash From Financing Activities 32.01M 1.562M 320.9M
Net Change In Cash 76.26M -109.1M 400.0M
YoY Change -240.9% -127.28% 2736.94%
FREE CASH FLOW
Cash From Operating Activities -$69.19M -$74.50M $3.007M
Capital Expenditures $8.261M -$11.79M -$5.780M
Free Cash Flow -$77.45M -$62.71M $8.787M
YoY Change -609.59% -813.66% -147.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4817000
dei Local Phone Number
LocalPhoneNumber
327-8775
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
BEAM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
4308000
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7024000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7474000
dei City Area Code
CityAreaCode
857
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
38600000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
28000
CY2021Q4 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
28921000
beam Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
8400000
CY2021Q4 beam Accrued Sub License Fees Current
AccruedSubLicenseFeesCurrent
38743000
beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
543000
dei Entity Central Index Key
EntityCentralIndexKey
0001745999
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#LicenseMember
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#LicenseMember
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#LicenseMember
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2022#LicenseMember
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39208
dei Entity Registrant Name
EntityRegistrantName
Beam Therapeutics Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5238376
dei Entity Address Address Line1
EntityAddressAddressLine1
238 Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
70468961
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156511000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
559994000
CY2022Q3 beam Available For Sale Debt Securities And Equity Securities Fv Ni Current
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiCurrent
938043000
CY2021Q4 beam Available For Sale Debt Securities And Equity Securities Fv Ni Current
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiCurrent
405653000
CY2021Q4 beam Collaboration Receivable Current
CollaborationReceivableCurrent
300000000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14358000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7360000
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
21300000
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
42200000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
159902000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
86270000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9823000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7540000
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2210000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2287000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
238859000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
213435000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
165075000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
31367000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
198288000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1108912000
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1273007000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111180000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84258000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
12750000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
12746000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115534000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
102718000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1874000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1724000
CY2022Q3 us-gaap Assets
Assets
1350250000
CY2021Q4 us-gaap Assets
Assets
1474453000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
134810000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1388000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39450000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
107102000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3007000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
31910000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
262303000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
253000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2793000
CY2022Q3 us-gaap Liabilities
Liabilities
635773000
CY2021Q4 us-gaap Liabilities
Liabilities
647715000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70468614
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68581251
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70457676
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68389425
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
705000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
684000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1737459000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1594378000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4674000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-50000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1019013000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-768274000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
714477000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
826738000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1350250000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1474453000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15799000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
763000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40883000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
775000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85287000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54623000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
225253000
us-gaap Operating Income Loss
OperatingIncomeLoss
-328981000
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-4900000
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
35800000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
70397000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
290306000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21815000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15774000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
65124000
us-gaap Operating Expenses
OperatingExpenses
290377000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Operating Income Loss
OperatingIncomeLoss
-249494000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.59
us-gaap Operating Expenses
OperatingExpenses
329756000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-91303000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-69634000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
20900000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8400000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
10431000
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4892000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-1378000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
21960000
CY2022Q3 beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
875000
CY2021Q3 beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
-10599000
beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
543000
beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
-9553000
CY2022Q3 beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
4982000
CY2021Q3 beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
9000
beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
7686000
beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
-63000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9638000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41516000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26665000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23050000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-81665000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28118000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-222829000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-305931000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2410000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2410000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-25500000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-25500000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-109575000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28118000
us-gaap Net Income Loss
NetIncomeLoss
-250739000
us-gaap Net Income Loss
NetIncomeLoss
-305931000
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-484000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-4624000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
28000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-110059000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28130000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-255363000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-305903000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.86
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-484000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-109575000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
714477000
us-gaap Profit Loss
ProfitLoss
-250739000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70343196
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70343196
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66377611
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66377611
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69758434
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69758434
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62960219
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62960219
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
245561000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
252005000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
120032000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4648000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1758000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-201560000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
422429000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
157785000
CY2021Q2 beam Stock Issued During Period Value Success Payment Liability
StockIssuedDuringPeriodValueSuccessPaymentLiability
30000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10452000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4083000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
55000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-76253000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
548551000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
318609000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12968000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1816000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28118000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
853814000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
826738000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1412000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53936000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18035000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
820000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2659000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-69214000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
829068000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
22300000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21578000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
646000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1481000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-71950000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
800161000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1664000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22209000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
502000
us-gaap Profit Loss
ProfitLoss
-305931000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-25500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10203000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
154953000
us-gaap Share Based Compensation
ShareBasedCompensation
61822000
us-gaap Share Based Compensation
ShareBasedCompensation
28068000
beam Change In Operating Lease Right Of Use Assets
ChangeInOperatingLeaseRightOfUseAssets
6237000
beam Change In Operating Lease Right Of Use Assets
ChangeInOperatingLeaseRightOfUseAssets
6781000
beam Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-20900000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7657000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
79578000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
734598000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-403479000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
449852000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33442000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1378609000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
606746000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
844524000
beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
-9553000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-1378000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
21960000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-63000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7192000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-733000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
197000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-527000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1341000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-25376000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2818000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
13496000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
15208000
beam Increase Decrease In Collaboration Receivable
IncreaseDecreaseInCollaborationReceivable
-300000000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-15883000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
49224000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2539000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-153000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
91718000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68098000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40690000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
422920000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
620000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-574775000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-216648000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
76365000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
737205000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3076000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
134000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
8688000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1697000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1576000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1968000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
572740000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177011000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
169261000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
626863000
us-gaap Interest Paid Net
InterestPaidNet
300000
us-gaap Interest Paid Net
InterestPaidNet
443000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5658000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7515000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
35877000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24164000
us-gaap Contribution Of Property
ContributionOfProperty
25500000
beam Fair Value Of Common Stock Issued To Settle Success Payment Liability
FairValueOfCommonStockIssuedToSettleSuccessPaymentLiability
30000000
beam Equity Issuance Costs In Accounts Payable And Accrued Expenses
EquityIssuanceCostsInAccountsPayableAndAccruedExpenses
118000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
36513000
beam Fair Value Of Equity Instruments Issued In Connection With Asset Acquisition
FairValueOfEquityInstrumentsIssuedInConnectionWithAssetAcquisition
120032000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1000000000.0
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1100000000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and the disclosure of contingent assets and liabilities as of and during the reporting period. The Company bases its estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, incremental borrowing rate used in the calculation of lease liabilities, research and development expenses, stock-based compensation, contingent consideration liabilities, success payments and certain judgements regarding revenue recognition. Actual results could differ from these estimates.</span></p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156511000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
612023000
CY2022Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
12750000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14840000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
169261000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
626863000
beam Debt Securities Available For Sale Maturity Period
DebtSecuritiesAvailableForSaleMaturityPeriod
less than one year
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
137406000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
100339000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26226000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16081000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111180000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84258000
CY2022Q3 us-gaap Depreciation
Depreciation
3473000
CY2021Q3 us-gaap Depreciation
Depreciation
1675000
us-gaap Depreciation
Depreciation
10153000
us-gaap Depreciation
Depreciation
4642000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
10431000
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4892000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-1378000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
21960000
CY2022Q3 beam Available For Sale Debt Securities And Equity Securities Fv Ni Amortized Cost Basis
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAmortizedCostBasis
942717000
CY2022Q3 beam Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Gain Before Taxes
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedGainBeforeTaxes
2000
CY2022Q3 beam Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Loss Before Taxes
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedLossBeforeTaxes
4676000
CY2022Q3 beam Available For Sale Debt Securities And Equity Securities Fv Ni
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNi
938043000
CY2021Q4 beam Available For Sale Debt Securities And Equity Securities Fv Ni Amortized Cost Basis
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAmortizedCostBasis
405703000
CY2021Q4 beam Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Gain Before Taxes
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedGainBeforeTaxes
32000
CY2021Q4 beam Available For Sale Debt Securities And Equity Securities Fv Ni Accumulated Gross Unrealized Loss Before Taxes
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNiAccumulatedGrossUnrealizedLossBeforeTaxes
82000
CY2021Q4 beam Available For Sale Debt Securities And Equity Securities Fv Ni
AvailableForSaleDebtSecuritiesAndEquitySecuritiesFvNi
405653000
CY2022Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2021Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12004000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11661000
CY2022Q3 beam Accrued Research Costs
AccruedResearchCosts
5363000
CY2021Q4 beam Accrued Research Costs
AccruedResearchCosts
3133000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3543000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3330000
CY2022Q3 beam Accrued Process Development And Manufacturing Costs
AccruedProcessDevelopmentAndManufacturingCosts
4601000
CY2021Q4 beam Accrued Process Development And Manufacturing Costs
AccruedProcessDevelopmentAndManufacturingCosts
3833000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13089000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6964000
CY2022Q3 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
38600000
CY2021Q4 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
28921000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5306000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
4557000
us-gaap Operating Lease Cost
OperatingLeaseCost
14161000
us-gaap Operating Lease Cost
OperatingLeaseCost
13660000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
643000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
588000
us-gaap Variable Lease Cost
VariableLeaseCost
3310000
us-gaap Variable Lease Cost
VariableLeaseCost
1162000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
38000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
383000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
308000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
761000
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
331000
us-gaap Sublease Income
SubleaseIncome
993000
CY2022Q3 us-gaap Lease Cost
LeaseCost
5656000
CY2021Q3 us-gaap Lease Cost
LeaseCost
5528000
us-gaap Lease Cost
LeaseCost
16786000
us-gaap Lease Cost
LeaseCost
15583000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2051846
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
4603000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3058000
us-gaap Operating Lease Payments
OperatingLeasePayments
14057000
us-gaap Operating Lease Payments
OperatingLeasePayments
7053000
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
250000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
35877000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24164000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4687000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
22629000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
23614000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
24179000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
21344000
CY2022Q3 beam Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
168733000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
265186000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
90288000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
174898000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-25500000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-25500000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Company’s common stock are entitled to one vote for each share of common stock.
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22209000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12968000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
61822000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28068000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7426084
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-109575000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6034192
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.40
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
62.32
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
369444
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
109531
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
55.89
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7607063
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
41.45
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3421139
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
24.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
41.84
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9254842
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28118000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-250739000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-305931000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70343196
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70343196
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66377611
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66377611
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69758434
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69758434
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62960219
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62960219
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.56
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.56
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.86
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2400000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
beam Number Of Founder Shareholders
NumberOfFounderShareholders
3

Files In Submission

Name View Source Status
0000950170-22-022322-index-headers.html Edgar Link pending
0000950170-22-022322-index.html Edgar Link pending
0000950170-22-022322.txt Edgar Link pending
0000950170-22-022322-xbrl.zip Edgar Link pending
beam-20220930.htm Edgar Link pending
beam-20220930.xsd Edgar Link pending
beam-ex31_1.htm Edgar Link pending
beam-ex31_2.htm Edgar Link pending
beam-ex32_1.htm Edgar Link pending
beam-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
beam-20220930_def.xml Edgar Link unprocessable
beam-20220930_lab.xml Edgar Link unprocessable
beam-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
beam-20220930_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
beam-20220930_cal.xml Edgar Link unprocessable